New aspects of pathogenesis, screening and prevention of preeclampsia

Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/485

Full metadata record

DC Field	Value	Language
dc.contributor.author	Dilufar Khodjaeva	-
dc.date.accessioned	2020-02-29T07:34:34Z	-
dc.date.available	2020-02-29T07:34:34Z	-
dc.date.issued	2019	-
dc.identifier.issn	2455-3301	-
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/485	-
dc.description.abstract	Complications of preeclampsia (PE) - the cause of 30% of maternal deaths and severe morbidity. To date, the pathogenesis of this terrible complication of gestation has not been fully studied, prevention issues are debated. The latest foreign studies from the PubMed, Medline and ISI Web of Knowledge databases on this issue summarize several aspects of PE pathogenesis: endoplasmic reticulum stress, apoptosis, endothelial cell activation, inflammatory response, microthrombosis and thrombotic microangiopathy (TMA), allogeneic incompatibility. Strategies for determining individual risk, screening and preventing PE are also considered.	en_US
dc.language.iso	other	en_US
dc.publisher	Tashkent	en_US
dc.subject	Keywords: Preeclampsia, hypertensive disorders, pathogenesis, complications of gestation, thrombotic microangiopathy, risk of preeclampsia, prevention of preeclampsia	en_US
dc.title	New aspects of pathogenesis, screening and prevention of preeclampsia	en_US
dc.type	Article	en_US
Appears in Collections:	Thesis, Articles

Files in This Item:

File	Description	Size	Format
19..pdf	New aspects of pathogenesis, screening and prevention of preeclampsia	291.31 kB	Adobe PDF	View/Open

DSpace JSPUI